Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties

Introduction. The importance of noroviruses in human infectious pathology and the danger of large epidemic outbreaks in organized groups determine the need to develop means of specific prevention of infection. The aim of the study was to obtain recombinant norovirus VP1 protein and analyze its im...

Full description

Saved in:
Bibliographic Details
Main Authors: Vladislav A. Lapin, Dmitry V. Novikov, Ekaterina V. Mokhonova, Dmitry A. Melentyev, Maria I. Tsyganova, Dmitry E. Zaitsev, Viktor V. Novikov
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2024-11-01
Series:Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
Online Access:https://microbiol.crie.ru/jour/article/viewFile/18687/1522
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550918667993088
author Vladislav A. Lapin
Dmitry V. Novikov
Ekaterina V. Mokhonova
Dmitry A. Melentyev
Maria I. Tsyganova
Dmitry E. Zaitsev
Viktor V. Novikov
author_facet Vladislav A. Lapin
Dmitry V. Novikov
Ekaterina V. Mokhonova
Dmitry A. Melentyev
Maria I. Tsyganova
Dmitry E. Zaitsev
Viktor V. Novikov
author_sort Vladislav A. Lapin
collection DOAJ
description Introduction. The importance of noroviruses in human infectious pathology and the danger of large epidemic outbreaks in organized groups determine the need to develop means of specific prevention of infection. The aim of the study was to obtain recombinant norovirus VP1 protein and analyze its immunogenic and antigenic properties . Materials and methods. Computer analysis of nucleotide and amino acid sequences, molecular cloning, polymerase chain reaction, electrophoresis of nucleic acids in agarose gel and proteins in polacrylamide gel, affinity chromatography, enzyme immunoassay. Results and discussion. A genetic construct encoding recombinant VP1 of the GII genotype norovirus with codons optimized for highly effective expression in Escherichia coli has been created. The strain of E. coli Rosetta 2 (DE3) has been transformed by genetic construct. VP1 expression was carried out in E. coli cells, conditions for its production, purification and renaturation were optimized. A purified soluble recombinant VP1 protein forms virus-like particles with a diameter of 30–50 nm. Immunization of BALB/c mice by protein lead to antibodies production with a titer greater than 1 : 1000. When evaluating antigenic properties, it was shown that human IgG, IgM, and IgA antibodies interact with recombinant VP1. The total antibody detection rate was 47,4%. The results indicate the possibility of using recombinant VP1 for development of domestic vaccine for the prevention of norovirus infection.
format Article
id doaj-art-711ef7d6602b43fdbb7870ded3d83c48
institution Kabale University
issn 0372-9311
2686-7613
language Russian
publishDate 2024-11-01
publisher Central Research Institute for Epidemiology
record_format Article
series Журнал микробиологии, эпидемиологии и иммунобиологии
spelling doaj-art-711ef7d6602b43fdbb7870ded3d83c482025-01-09T20:09:08ZrusCentral Research Institute for EpidemiologyЖурнал микробиологии, эпидемиологии и иммунобиологии0372-93112686-76132024-11-01101566166710.36233/0372-9311-5522787Production of recombinant norovirus VP1 protein and its antigenic and immunogenic propertiesVladislav A. Lapin0https://orcid.org/0000-0002-5905-5722Dmitry V. Novikov1https://orcid.org/0000-0001-7049-6935Ekaterina V. Mokhonova2https://orcid.org/0000-0002-9742-7646Dmitry A. Melentyev3https://orcid.org/0000-0002-2441-6874Maria I. Tsyganova4https://orcid.org/0000-0002-2811-6844Dmitry E. Zaitsev5https://orcid.org/0000-0002-7663-6924Viktor V. Novikov6https://orcid.org/0000-0002-2449-7213Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and MicrobiologyAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and MicrobiologyAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and MicrobiologyAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and MicrobiologyAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and MicrobiologyAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and MicrobiologyAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and MicrobiologyIntroduction. The importance of noroviruses in human infectious pathology and the danger of large epidemic outbreaks in organized groups determine the need to develop means of specific prevention of infection. The aim of the study was to obtain recombinant norovirus VP1 protein and analyze its immunogenic and antigenic properties . Materials and methods. Computer analysis of nucleotide and amino acid sequences, molecular cloning, polymerase chain reaction, electrophoresis of nucleic acids in agarose gel and proteins in polacrylamide gel, affinity chromatography, enzyme immunoassay. Results and discussion. A genetic construct encoding recombinant VP1 of the GII genotype norovirus with codons optimized for highly effective expression in Escherichia coli has been created. The strain of E. coli Rosetta 2 (DE3) has been transformed by genetic construct. VP1 expression was carried out in E. coli cells, conditions for its production, purification and renaturation were optimized. A purified soluble recombinant VP1 protein forms virus-like particles with a diameter of 30–50 nm. Immunization of BALB/c mice by protein lead to antibodies production with a titer greater than 1 : 1000. When evaluating antigenic properties, it was shown that human IgG, IgM, and IgA antibodies interact with recombinant VP1. The total antibody detection rate was 47,4%. The results indicate the possibility of using recombinant VP1 for development of domestic vaccine for the prevention of norovirus infection.https://microbiol.crie.ru/jour/article/viewFile/18687/1522norovirusvp1virus-like particlesvaccine
spellingShingle Vladislav A. Lapin
Dmitry V. Novikov
Ekaterina V. Mokhonova
Dmitry A. Melentyev
Maria I. Tsyganova
Dmitry E. Zaitsev
Viktor V. Novikov
Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
Журнал микробиологии, эпидемиологии и иммунобиологии
norovirus
vp1
virus-like particles
vaccine
title Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
title_full Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
title_fullStr Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
title_full_unstemmed Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
title_short Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
title_sort production of recombinant norovirus vp1 protein and its antigenic and immunogenic properties
topic norovirus
vp1
virus-like particles
vaccine
url https://microbiol.crie.ru/jour/article/viewFile/18687/1522
work_keys_str_mv AT vladislavalapin productionofrecombinantnorovirusvp1proteinanditsantigenicandimmunogenicproperties
AT dmitryvnovikov productionofrecombinantnorovirusvp1proteinanditsantigenicandimmunogenicproperties
AT ekaterinavmokhonova productionofrecombinantnorovirusvp1proteinanditsantigenicandimmunogenicproperties
AT dmitryamelentyev productionofrecombinantnorovirusvp1proteinanditsantigenicandimmunogenicproperties
AT mariaitsyganova productionofrecombinantnorovirusvp1proteinanditsantigenicandimmunogenicproperties
AT dmitryezaitsev productionofrecombinantnorovirusvp1proteinanditsantigenicandimmunogenicproperties
AT viktorvnovikov productionofrecombinantnorovirusvp1proteinanditsantigenicandimmunogenicproperties